Volume 54, 1996 author index

Pharmacology

Biochemistry

and Behavior, Vol. 54, No. 4, pp. III-XV, 1996 Copyright 0 1996 Elsevier Science Inc. Printed in the USA. AI1rights reserved. 0091-3057/96 $15.00 + .OO

ELSEVIER

CONTENTS VOLUME 54, 1996 VOLUME 54 NUMBER 1 1996

CONTENTS

Special Issue: Anxiety, Editorial. FILE, S. E.

Stress, and Depression

..........................................................................................................

1

Recent developments in anxiety, stress, and depression. FILE, S. E. .......................................... ................................................................

3

Exploration and predation models of anxiety: Evidence from laboratory and wild species. HENDRIE, C. A., S. M. WEISS and D. EILAM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . .

13

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. ........................................................................................................... HOGG, S.

21

The influence of open arm ledges and maze experience in the elevated plus-maze. ............................................................................. FERNANDES, C. and S. E. FILE

31

Plus-maze retest profile in mice: Importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade. RODGERS, R. J., N. J. T. JOHNSON, J. C. COLE, C. V. DEWAR, G. R. KIDD and P. H. KIMPSON .............................................................................................

41

The pituitary-adrenal McNAUGHTON,

51

Articles

axis and the different behavioral effects of buspirone and chlordiazepoxide. N., K. S. PANICKAR and B. LOGAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . .

Muscarinic antagonists are anxiogenic SMYTHE, J. W., D. MURPHY,

in rats tested in the black-white box. S. BHATNAGAR, C. TIMOTHY and B. COSTALL

........

57

..............................................

65

Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors. PRZEGALINSKI, E., E. TATARCZYNSKA, A. DEREK-WESOIEK, and E. CHOJNACKA-WGJCIK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . .

73

Modulation of plus-maze behaviour in mice by the preferential D,-receptor agonist 7-OH-DPAT. ........................ RODGERS, R. J., N. J. T. JOHNSON, A. J. CHAMPION and S. MILLS

79

Behavioural and neurocbemical responses of male and female chicks to cat odour. .............................................. FLUCK, E., S. HOGG, P. S. MABBUTT and S. E. FILE

85

Relationship between memory and fear: Developmental and pharmacological PLETNIKOV, M. V., Z. I. STOROZHEVA and V. V. SHERSTNEV

93

NGF regulatory role in stress and coping of rodents and humans. ALLEVA, E., S. PETRUZZI, F. CIRULLI and L. ALOE

III

studies. ...............................

CONTENTS

IV Affiliation in periadolescent rats: Behavioral and corticosterone response to social reunion with familiar or unfamiliar partners. ................................................. CIRULLI, F., M. L. TERRANOVA and G. LAVIOLA

Strain differences in fear-motivated behavior of rats. REX, A., U. SONDERN, J. P. VOIGT, S. FRANCK and H. FINK

99

.................................

107

Behavioral stress response of genetically selected aggressive and nonaggressive wild house mice in the shock-probe/defensive burying test. ..................... SLUYTER, F., S. M. KORTE, B. BOHUS and G. A. VAN OORTMERSSEN

113

Differences in benzodiazepine binding in quail selectively bred for differences in tonic immobility. ................................................................... HOGG, S., A. D. MILLS and S. E. FILE

117

Anxiolytic effects in the plus-maze of S-I-IT,,-receptor ligands in dorsal raphe and ventral hippocampus. ........................................................................... FILE, S. E. and L. E. GONZALEZ

123

Role of 5-HT in stress, anxiety, and depression. GRAEFF, F. G., F. S. GUIMARAES, T. G. C. S. DE ANDRADE

....

129

Role of 5-HT,, receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. ................................................ INVERNIZZI, R., M. BRAMANTE and R. SAMANIN

143

Effects of psychotropic drugs on rat responding in an operant paradigm involving choice between delayed reinforcers. CHARRIER, D. and M. H. THIGBOT .._...................................................................

149

Effects of the 5-HT,, antagonist (+)-WAY-100135 on murine social and agonistic behavior. ........................................................... BELL, R., P. J. MITCHELL and H. HOBSON

159

Selective effects of 8-OH-DPAT on social competition in the rat. WOODALL, K. L., A. M. DOMENEY and M. E. KELLY

.............................................

169

Effects of chlordiazepoxide on maternal aggression in mice depend on experience of resident and sex of intruder. ........................ PALANZA, P., R. J. RODGERS, P. F. FERRARI and S. PARMIGIANI

175

Prenatal naltrexone facilitates male sexual behavior in the rat. COHEN, E., G. KESHET, Y. SHAVIT and M. WEINSTOCK

........................................

183

Involvement of the 5-HT,, subtype receptor in the neonatal organization of agonistic behaviour in the rat. ALBONETTI, E., M. I. GONZALEZ, A. SIDDIQUI, C. A. WILSON and F. FARABOLLINI . . . . . . . . . . .. ... . ... .. . .. ... .. .. .. .. .. ... . .. .. .. . .. . .. ... .. . ... .. .. .. .. .. ... . . ... .. .. ...

189

Neonatal organizational effects of the 5-HT, and 5-HT,, subsystems on adult behavior in the rat. GONZALEZ, M. I., E. ALBONETTI, A. SIDDIQUI, F. FARABOLLINI and C. A. WILSON .............................................................................................................

195

Stress-induced increase in brain neuroactive steroids: Antagonism by abecarnil. BARBACCIA, M. L., G. ROSCETTI, F. BOLACCHI, A. CONCAS, M. C. MOSTALLINO, R. H. PURDY and G. BIGGIO ......................................... .......................................

205

and J. F. W. DEAKIN

CONTENTS

V

Stress: A major variable in the psychopharmacologic response. ................................................................................................ STANFORD, S. C.

211

Psychosocial stress in tree shrews: Clomipramine counteracts behavioral and endocrine changes. .......................... FUCHS, E., M. KRAMER, B. HERMES, P. NETTER and C. HIEMKE

219

Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats. ..................................................................... GORKA. Z., E. MORYL and M. PAPP

229

Indirect dopamine agonists effects on despair test: Dissociation from hyperactivity. VAUGEOIS, J.-M., D. POUHg, F. ZUCCARO and J. COSTENTIN f.............................

23.5

Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. SALMINEN, O., S. LAHTINEN and L. AHTEE .........................................................

241

Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice. GROENINK, L., J. VAN DER GUGTEN, T. J. J. ZETHOF, J. A. M. VAN DER HEYDEN and B. OLIVIER . . . . . . . . . . . . . . .._..................................................................................

249

Effects of the novel cholecystokinin analogue Sue-Trp-N(Me)-Nle-Asp-Phe-NH, on feeding and cortisol release in pigs. EBENEZER, I. S., R. F. PARROTT and J. A. GOODE f...............................................

255

Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety. KORTE, S. M., G. A. H. KORTE-BOUWS, G. F. KOOB, E. R. DE KLOET and B. BOHUS .....................................................................................................

261

Differential effects of gonadectomy on the thymocyte phenotypic profile in male and female rats. LEPOSAVIC, G., B. KARAPETROVIC, S. OBRADOVIC, D. VIDIC DANKOVIC and D. KOSEC . . . . . . . . . . . . .._......................................................................................

269

Met-enkephalin modulates stress-induced alterations of the immune response in mice. MAROTTI, T., J. GABRILOVAC, S. RABATIC, L. SMEJKAL-JAGAR, B. ROCIC and H. HABERSTOCK ..........................................................................................

277

Activation of the HPA axis by immune insults: Roles and interactions of cytokines, eicosanoids, and glucocorticoids. BUCKINGHAM, J. C., H. D. LOXLEY, H. C. CHRISTIAN and J. G. PHILIP ................

285

Stress and the immune system in the etiology of anxiety and depression. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . LEONARD, B. E. and C. SONG

299

Corticotropin releasing factor and its binding protein. LOWRY, P. J., R. J. WOODS and S. BAIGENT

305

CONTENTS

.........................................................

VOLUME

54 NUMBER

2 1996

Effects of caffeine, practice, and mode of presentation on stroop task performance. EDWARDS, S., C. BRICE, C. CRAIG and R. PENRI-JONES .......................................

309

Effects of cold acclimation and central opioid processes on thermoregulation in rats. ........................................................................ WILSON, J. R. and B. A. HOWARD

317

Articles

VI

CONTENTS Inhibitory effect of restraint on induction of behavioral sensitization to methamphetamine and cocaine in mice. .................................................. .. . . .. ..................................... KURIBARA, H.

321

Naloxone decreases intake of 10% sucrose in preweanling rats. PHILOPENA, J., D. GREENBERG and G. P. SMITH

.................................................

333

Methadone produces conditioned place preference in the rat. STEINPREIS, R. E., A. L. RUTELL and F. A. PARRETT

...........................................

339

Possible novel pharmacodynamic action of cocaine: Cardiovascular and behavioral evidence. ... .. . .. ... . .. ... . ... .. . .. .. . .. ... .. . .. .. ... .. .. .. ... .. ... .. .. ... . . .. . . . .. . . .. .. . ... .. ... .. .. TELLA, S. R.

343

Behavioral Effects of the Putative Anxiolytic ( f )-l-(2,5-dimethoxy-4-ethylthiophenyl)-2aminopropane (ALEPH-2) in rats and mice. SCORZA, M. C., M. REYES-PARADA, R. SILVEIRA, H. VIOLA, J. H. MEDINA, ............................................. M. B. VIANA, H. ZANGROSSI, JR. and F. G. GRAEFF

355

Supraspinal delta, opioid agonist analgesia in Swiss-Webster mice involves spinal GABA, receptors. RADY, J. J. and J. M. FUJIMOTO ..................................................................... . .

363

Morphine- and cocaine-induced conditioned place preference: Effects of quinpirole and preclamol. KIVASTIK, T., K. VUORIKALLAS, T. P. PIEPPONEN, A. ZHARKOVSKY and ............................................................. ..............................................

L. AHTEE

Further investigation of allopurinol brain stem of the rat. DESOLE,

effects on MPTP-induced

M. S., G. ESPOSITO,

L. FRESU,

371

oxidative stress in the striatum and

R. MIGHELI,

S. SIRCANA,

R. DELOGU,

........................................ ..............................................

377

Changes in monoamines and their metabolite concentrations in REM sleep-deprived rat forebrain nuclei. FAROOQUI, S. M., J. W. BROCK and J. ZHOU ........................................................

385

Diazepam modulates the period of locomotor light-induced phase advances. SUBRAMANIAN P. and R. SUBBARA

393

M. MIELE

and E. MIELE

Ethanol anapyrexia in rats. BRIESE, E. and L. HERNANDEZ

rhythm in mice (mus Boodugu) and attenuates

. ,..................................................................

...........................................................................

Ca”+/calmodulin system: Participation in the progesterone-induced facilitation in the ovariectomized estrogen-primed rat. CANCHOLA, E., M. RODRIGUEZ-MEDINA, H. DUENAS-TENTORI, and A. ROSADO

Salbutamol antagonized induced hyperphagia. NISOLI,

. . . . . . . . . ... .. .. .. .. ..

E., V. GAROSI,

of lordosis behavior E. MERCADO

.. . .. .. .. .. ... .. .. .. . .. ... .. .. ... . .. ... . .. .... . ... ... .. ... .. .. .. .. ... .. . ...

insulin- and sodium mercaptoacetate-induced J. E. BLUNDELL

LIU, W.-F.

antiparkinsonian

403

but not 2-deoxy-o-glucose-

and M. 0. CARRUBA

................................

Metabolic mapping of the effects of chronic voluntary ethanol consumption in rats. WILLIAMS-HEMBY, L., K. A. GRANT, G. J. GATT0 and L. J. PORRINO

Effects of antimuscarinic

399

drugs on brightness discrimination

..... . .... .....

409

415

performance in rats.

..........................................................................................................

425

VII

CONTENTS Effects of Nw-nitro+arginine methyl ester on henzodiazepine binding in some limbic areas of hyperlipidaemic rats. FACCIOLO, R. M., R. TAVOLARO, A. CHINELLATO, E. RAGAZZI, M. CANONACO and G. FASSINA . .. . .. ... . .. ... . .. .. . .. .. . .. .. .. . .. .. .. ... . ... .. .. . .. .. .. .. .. .. ... . .. .. .. .. .. .. .. ... ... .. .. .. .. .

431

Dopamine D,/D, antagonist of cocaine. GETHER-DOUGLASS,

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .._.._.........

439

and D, receptors in memory. .............................................................

453

Naloxone-precipitated changes in hiogenic amines and their metabolites in various brain regions of butorphanol-dependent rats. TOKUYAMA, S., H. WAKABAYASHI, B. HOSKINS and I. K. HO ...............................

461

Comparison of the effects of prototypical behavioral stimulants on locomotor activity and rotational behavior in rats. GARRETT, B. E. and S. G. HOLTZMAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .._.............

469

combination

as antagonists

B. and A. L. RILEY

Regional brain patterns of dopamine, metabolites GALKINA. 0. V. and E. K. PODGORNAYA

Development of an affordable hi-resolution TEICHER, M. H., S. L. ANDERSEN,

of the discriminative

stimulus effects

activity monitor system for laboratory animals. P. WALLACE, D. A. KLEIN and J. HOSTETTER

..

419

Acute and chronic effects of morphine in pigeons responding under a progressive-ratio schedule of food delivery. POLING, A., M. LESAGE, D. ROE and D. SCHAEFER ..............................................

485

Cocaethylene-induced S. M. MEEHAN

491

kindling of seizure effects: Cross-specificity with cocaine. and M. D. SCHECHTER .................................................................

Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEAformalin test. LUFTY, K., B. SADOWSKI, P. MAREK, I.-S. KWON, J. F. KEANA and E. WEBER

in the

... .. . .

495

Lack of acute tolerance development to the subjective, cognitive, and psychomotor effects of nitrous oxide in healthy volunteers. YAJNIK, K., J. P. ZACNY, C. J. YOUNG, J. L. LICHTOR, G. RUPANI, M. M. KLAFTA, D. W. COALSON and J. L. APFELBAUM ................................................................

501

Preclinical profile of the mixed 5-HT,,/5-HT,, receptor antagonist S 21357. GRIEBEL, G., D. C. BLANCHARD, M.-C. RETTORI, B. GUARDIOLA-LEMAITRE and R. J. BLANCHARD .................................................................................. ............

509

Discriminative stimulus effects of dopaminergic agents in Rhesus monkeys. KOETZNER, L., A. L. RILEY and J. R. GLOWA .......................................................

517

Nerotensin levels and receptors in HAS and LAS rat brains: Effects of ethanol. ERWIN, V. G., L. J. DRASKI and R. A. DEITRICH f..................................................

525

CONTENTS

VIII

VOLUME 54 NUMBER 3 1996

CONTENTS

Articles Detailed investigations DE LA GARZA,

of S-HT, compounds

in a drug discrimination model. and K. A. CUNNINGHAM

R., II, P. M. CALLAHAN

. . . . . . . . . . . . . . . . . . . . . ..f..

533

Effects of ethanol in a putative rodent model of tardive dyskinesa. ............... .......................................................................................... STOESSL, A. J.

541

Orally delivered methadone as a reinforcer for rhesus monkeys: The relationship between drug concentration and choice. MEISCH, R. A., R. B. STEWART and N.-S. WANG ........................................ ...........

547

Ethanol effect on activation and maintenance of cold stress response in immature rats. SPIERS, D. E., S. A. KELLEHER and P. A. EICHEN .................................................

555

Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens. ... . . . . . NARAYANAN, S., D. WILLINS, A. DALIA, L. WALLACE and N. URETSKY

565

Unsignaled morphine delivery does not disrupt the development of associative morphine tolerance in the rat. CEPEDA-BENITO, A. and S. T. TIFFANY ...............................................................

575

Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF. MALIN, D. H., J. R. LAKE, P. E. SHORT, J. B. BLOSSMAN, B. A. LAWLESS, C. K. ................. ...................... SCHOPEN, E. E. SAILER, K. BURGESS and 0. B. WILSON

581

Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice. ... . . . . .. . . . . .. . ROBINSON, S. F., E. U. GRUN, J. R. PAULY and A. C. COLLINS

587

Effect of amphetamine on behavior maintained and food restriction. SLAWECKI, C. J. and H. H. SAMSON

....................................................................

595

Differential sexual activity of isolated and group-housed male mice: Influence of acute d-amphetamine sulfate administration. .................................................................. DECATANZARO, D. and J. GRIFFITHS

601

Dose-dependent decrements in adult male rat sexual behavior after neonatal clorimipramine treatment. .................................... VOGEL, G., M. HAGLER, A. HENNESSEY and C. RICHARD

605

Inhibitors of protein and RNA synthesis block context memory and long-term habituation in the crab Chasmagnathus. .............. ............................... PEDREIRA, M. E., B. DIMANT and H. MALDONADO

611

Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements. CHESLER. E. J. and J. D. SALAMONE .................................... ...............................

619

by sucrose: Interaction of reinforcement

schedule

CONTENTS

IX

Type A CCK receptors mediate satiety effects of intestinal nutrients. ......................................................................... BRENNER L. A. and R. C. RITTER

625

Phenobarbital in the anticonvulsant dose range does not impair learning and memory or alter brain AChE activity or monoamine levels. ................................................ SUDHA, S., M. K. LAKSHMANA and N. PRADHAN

633

CONTENTS

1996

VOLUME

54 NUMBERS

ERRATUM For Pharmacology Biochemistry and Behavior, Volume 54 Number 2, there is an error on the cover and spine. They should read June 1996, not May 1996.

Articles Chronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock. .... ...................... GASIOR, M., K. BOROWICZ, Z. KLEINROK and S. J. CZUCZWAR

639

The influence of opioid antagonists on the discriminative stimulus effects of ethanol. .,................................................................................................. SPANAGEL, R.

645

Daily rhythms in spontaneous and diazepam-induced anxiolysis in Syrian hamsters. ................ ............. YANNIELLI, P. C., B. I. KANTEREWICZ and D. P. CARDINAL1

651

Conditioned taste aversion and place preference induced by the calcium channel antagonist nimodipine in rats. ........................... ................. ............. DE BEUN, R., A. LOHMANN and J. DE VRY

657

Individual differences in sugar consumption following systemic or intraaccumbens administration of low doses of amphetamine in nondeprived rats. ................................................................. ..... SILLS, T. L. and F. J. VACCARINO

665

The effect of ginseng extract on locomotor sensitization and conditioned place preference induced by methamphetamine and cocaine in mice. .......................... ................. ..... TOKUYAMA, S., M. TAKAHASHI and H. KANETO

671

Pre- or postsynaptic activity of 5-HTIA compounds in mice depends on the anxiety paradigm. LOPEZ-RUBALCAVA, C. ..... ................. ................................ .................. ............

677

Effect of repeated methamphetamine pretreatment on freezing behavior induced by conditioned fear stress. .............. ............................................. TSUCHIYA, K., T. INOUE and T. KOYAMA

687

Duration of sucrose availability differentially alters morphine-induced D’ANCI, K. E., R. B. KANAREK and R. MARKS-KAUFMAN

analgesia in rats. ....................................

693

Female rats that rapidly acquire a d-amphetamine discrimination generalize more to d-amphetamine. ............ ................................................... ..... TOMIE, A. and E. M. MOSAKOWSKI

699

Receptor subtype mediation of feeding suppression by bombesin-like peptides. ............... ................. ............ LADENHEIM, E. E., K. E. WIRTH and T. H. MORAN

705

X

CONTENTS Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. MARTINET, L., B. GUARDIOLA-LEMAITRE and E. MOCAER .................... ............

713

Intake of dietary sucrose or fat reduces amphetamine drinking in rats. KANAREK, R. B., W. F. MATHES and J. PRZYPEK ................................................

719

Additive effects of glyburide and antidepressants in the forced swimming test: Evidence for the involvement of potassium channel blockade. GUO, W., K. TODD, M. BOURIN, M. HASCOET and F. KOUADIO .... ......................

725

The role of nitric oxide in soman-induced seizures, neuropathology, and lethality. LALLEMENT, G., T.-M. SHIH, I. PERNOT-MARINO, D. BAUBICHON, A. FOQUIN and J. H. McDONOUGH ...... ................................................................................

731

Oral intake of sweetened or sweetened alcoholic beverages and open-field behavior. NADAL, R. A., M. A. PALLARES and N. S. FERRY ................... ................. ............

739

Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence. HALFORD, J. C. G. and J. E. BLUNDELL ...................... .......................................

745

Alternating lever cyclic-ratio schedule analysis of the effects of atropine sulfate. WELDON, D. T., E. O’HARE, M. A. KUSKOWSKI, J. CLEARY and J. R. MACH, JR. .. ................. ................. ................. .................................. .....

753

Expression of epileptiform activity induced by a penicillin focus within the posterior thalamus in the awake rat. HORN, E. and B. GEHRING ................................... ..............................................

759

Behavioral effects of naloxone on neuropeptide Y-induced feeding. RUDSKI, J. M., M. GRACE, M. A. KUSKOWSKI, C. J. BILLINGTON and A. S. LEVINE .................................................. ................. .............................

771

Behavioral and neurochemical effects induced by chronic L-DOPA administration. MOLINENGO, L., I. SCORDO, B. PASTORELLO, M. ORSETTI and P. GHI

779

... ............

Behavioural and neurochemical sensitization of morphine-withdrawn rats to quinpirole. PIEPPONEN, T. P., J. KARAJAMAKI, T. KIVASTIK, A. ZHARKOVSKY and L. AHTEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..,..........................

787

VOLUME 54, 1996 AUTHOR INDEX Ahtee, L., 241, 371 787 Albonetti, E., 189, 195 Aloe, L., 65 Alleva, E., 65 Andersen, S. L., 479 Apfelbaum, J. L., 501 Baigent, S., 305 Barbaccia, M. L., 205 Baubichon, D., 73 1 Bell, R., 159 Bhatnagar, S., 57 Biggio, G., 205 Billington, C. J., 771 Blanchard, D. C., 509 Blanchard, R. J., 509 Blossman, J. B., 581 Blundell, J. E., 409, 745 Bohus, B., 113, 261 Bolacchi, F., 205 Borowicz, K., 639 Bourin, M., 725 Bramante, M., 143 Brenner, L. A., 625 Brice, C., 309 Briese, E., 399 Brock, J. W., 385 Buckingham, J. C., 285 Burgess, K., 581 Callahan, P. M., 533 Canchola, E., 403 Canonaco, M., 431 Cardinali, D. P., 651 Carruba, M. O., 409 Cepeda-Benito, A., 575 Champion, A. J., 79 Charrier, D., 149 Chesler, E. J., 619 Chinellato, A., 431 Chojnacka-Wojcik, E., 73 Christian, H. C., 285 Cirulli, F., 65, 99 Cleary, J., 753 Coalson, D. W., 501 Cohen, E., 183 Cole, J. C., 41 Collins, A. C., 587 Concas, A., 205 Costall, B., 57 Costentin, J., 235 Craig, C., 309 Cunningham, K. A., 533 Czuczwar, S. J., 639 Dalia, A., 565 D’Anci, K. E., 693 DE Andrade, T. G. C. S., 129 Deakin, J. F. W., I29 De Beun, R., 657 DECatanzaro, D.. 601 Deitrich, R. A., 525 DE Kloet. E. R.. 261 DE LA Garza, R., II, 533 Delogu, R., 377

Hernandez, L., 399 Hiemke, C., 219 Ho, I. K., 461 Hobson, H., 159 Hogg, S., 21, 85, 117 Holtzman, S. G., 469 Horn, E., 759 Hoskins, B., 461 Hostetter, J., 479 Howard, B. A., 317

Dereti-Wesolek, A., 73 Desole, M. S., 377 De Vry, J., 657 Dewar, C. V., 41 Dimant, B., 611 Domeney, A. M., 169 Draski, L. J., 525 Dueiias, H., 403 Ebenezer, I. S., 255 Edwards, S., 309 Eichen, P. A., 555 Eliam, D., 13 Erwin, V. C., 525 Esposito, G., 377

Inoue, T., 687 Invernizzi, R., 143 Johnson,

Facciolo, R. M., 431 Farabollini, F., 189, 195 Farooqui, S. M., 385 Fassina, G., 43 1 Fernandes, C., 31 Ferrari, P. F., 175 Ferre, N. S., 739 File, S. E., 3, 31, 85, 117, 123 Fink, H., 107 Fluck, E., 85 Foquin, A., 731 Franck, S., 107 Fresu, L., 377 Fuchs, E., 219 Fujimoto, J. M., 363

N. J. T., 41, 79

Kanarek, R. B., 693, 719 Kaneto, H., 671 Kanterewicz, B. I., 651 Karapetrovic, B., 269 Katajamaki, J., 787 Keana, J. F. W., 495 Kelleher. S. A.. 555 Kelly, M. E., 169 Keshet, G., 183 Kidd. G. R.. 41 Kimpson, PI H., 41 Kivastik, T., 371, 787 Klafta, J. M., 501 Klein, D. A., 479 Kleinrok. Z.. 639 Koetzner, L., 517 Koob, G. F., 261 Korte-Bouws, G. A. H., 261 Korte, S. M., 113, 261 Kosec, D., 269 Kouadio, F., 725 Koyama, T., 687 Kramer, M., 219 Kuribara, H., 327 Kuskowski, M. A., 753, 771 Kwon, I.-S., 495

Gabrilovac, J., 277 Galkina, 0. V., 453 Garosi, V., 409 Garrett, B. E., 469 Gasior, M., 639 Gatto. G. J., 415 Gehring, B., 759 Geter-Douglass, B., 439 Ghi, P., 779 Glowa, J. R., 517 Gonzalez, L. E., 123 Gonzalez, M. I., 189, 195 Goode, J. A., 255 Gorka, Z.. 229 Grace,.M.; 771 Graeff, F. G., 129, 355 Grant, K. A., 415 Greenberg, D., 333 Griebel, G., 509 Griffiths, J., 601 Groenink, L., 249 Grun, E. U., 587 Guardiola-Lemaitre, B., 509,713 GuimaraPs, F. S., 129 Guo, W., 725 Haberstock, H., 277, 713 Hagler, M., 605 Halford, J. C. G., 745 Hascoet, M., 725 Hendrie, C. A., 13 Hennessey, A., 605 Hermes, B., 219

XI

Maldonado, H., 611 Malin, D. H., 581 Marek, P., 495 Marks-Kaufman, R., 693 Marotti, T., 277 Martinet, L., 713 Mathes, W. F., 719 McDonough, J. H., 731 Mcnaughton, N., 51 Medina, J. H., 355 Meehan, S. M., 491 Meisch, R. A., 547 Mercado, R., 403 Miele, E., 377 Miele, M., 377 Migheli, R., 377 Mills, A. D., 117 Mills, S., 79 Mitchell, P. J., 159 Mocaer, E., 713 Molinengo, L., 779 Moran, T. H., 705 Moryl, E., 229 Mosakowski, E. M., 699 Mostallino, M. C., 205 Murphy, D., 57 Nadal, R. A., 739 Narayanan, S., 565 Netter, P., 219 Nisoli, E., 409 Obradovic, O’Hare, E., Olivier, B., Orsetti, M.,

S., 269 753 249 779

Ladenheim, E. E., 705 Lahtinen, S., 241 Lake, J. R., 581 Lakshmana, M. K., 633 Lallement, G., 731 Laviola, G., 99 Lawless, B. A., 581 Leonard, B. E., 299 Leposavic, G., 269 Lesage, M., 485 Levine, A. S., 771 Lichtor, J. L., 501 Liu, W. F., 425 Logan, B., 51 Lohmann, A., 657 Lopez-Rubalcava, C., 677 Lowry, P. J., 305 Loxley, H. D., 285 Lutfy, K., L., 495

Palanza, P., 175 Pallares, M. A., 739 Panickar, K. S., 51 Papp, M., 229 Parmigiani, S., 175 Parrett, F. A., 339 Parrott, R. F., 255 Pastorello, B., 779 Pauly, J. R., 587 Pedreira, M. E., 611 Penri-Jones, R., 309 Pernot-Marino, I., 731 Petruzzi, S., 65 Philip, J. G., 285 Philopena, J., 333 Piepponen, T. P., 371, 787 Pletnikov, M. V., 93 Podgornaya, E. K., 453 Poling, A., 485 Porrino, L. J., 415 Pouhe, D., 235 Pradhan, N., 633 Przegalinski, E., 73 Przypek, J., 719 Purdy, R. H., 205

Mabbutt, P. S., 85 Mach, J. R., Jr., 753

Rabatic, S., 277 Rady, J. J., 363

AUTHOR

XII Ragazzi, E., 43 1 Rettori. M.-C.. 509 Rex, A., 107 Reyes-Parada, M., 355 Richard, C., 605 Riley, A. L., 439, 517 Ritter, R. C., 625 Robinson, S. F., 587 Rocic, B., 277 Rodgers, R. J., 41, 79, 175 Rodimez-Medina, M., 403 Roe, D., 485 Rosado, A., 403 Roscetti, G., 205 Rudski, J. M., 771 Rupani, G., 501 Rutell, A. L., 339 Sadowski, B., 495 Sailer, E. E., 581 Salamone, J. D., 619 Salminen, O., 241 Samanin, R., 143 Samson, H. H.. 595 Schaefer, D., 485 Schechter, M. D., 491 Schopen, C. K., 581

Scordo, I., 779 Scorza, M. C., 355 Shavit, Y., 183 Sherstnev, V. V., 93 Shih, T., 731 Short, P. E., 581 Siddiqui, A., 189, 195 Sills, T. L., 665 Silveira, R., 355 Sircana, S., 377 Slawecki, C. J., 595 Sluyter, F., 113 Smejkal-Jagar, L., 277 Smith, 0. P., 333 Smythe, J. W., 57 Sondern, U., 107 Song, C., 299 Spanagel, R., 645 Spiers, D. E., 555 Stanford, S. C., 211 Steinpreis, R. E., 339 Stewart, R. B., 547 Stoessl, A. J., 541 Storozheva, Z. I., 93 Subbaraj, R., 393 Subramanian, P., 393 Sudha, S., 633

Takahashi, M., 671 Ta.tarczynSka, E., 73 Tavolaro, R., 431 Teicher, M. H., 479 Tella, S. R., 343 Terranova, M. L., 99 Thitbot, M. H., 149 Tiffany, S. T., 575 Timothy, C., 57 Todd, K., 725 Tokuyama, S., 461, 671 Tomie, A., 699 Tsuchiya, K., 687 Uretsky,

N., 565

Vaccarino, F. J., 665 VAN Oortmerssen, G. A., 113 VAN DER Gugten, J., 249 VAN DER Heyden, J. A. M., 249 Vaugeois, J.-M., 235 Viana, M. B., 355 VidiC Dankovic, B., 269 Viola, H., 355 Vogel, G., 605 Voigt, J. P., 107 Vuorikallas, K., 371

INDEX

Wakabayashi, H., 461 Wallace, L., 565 Wallace, P., 479 Wang, N.-S., 547 Weber, E., 495 Weinstock, M., 183 Weiss, S. M., 13 Weldon, D. T., 753 Williams-Hemby, L., 415 Willins, D., 565 Wilson, C. A., 189, 195 Wilson, J. R., 317 Wilson, 0. B., 581 Wirth, K. E., 705 Woodall, K. L., 169 Woods, R. J., 305 Yajnik, S., 501 Yannielli, P. C., 651 Young, C. J., 501 Zacny, J. P., 501 Zangrossi JR., H., 355 Zethof, T. J., 249 Zharkovsky, A., 371, 787 Zuccaro, F., 235 Zhou, J., 385

KEYWORD Abecarnil, 205 ACEAI, 495 Acetylcholine, 57, 619 AChE activity, 633 ACTH, 249 Actinomycin-D, 611 Activity, 479, 739 Acute drug tolerance, 501 Adrenals, 51 Adult agonistic behavior, 189 Aggression, 113 Agonistic behavior 5-HTIA antagonist, 159 Alcohol, 54 1 Alcohol binding site, 117 ALEPH-2, 355 Allopurinol, 377 (allotetrahydrodeoxycorticosterone, THDOC), 205 Ambulation, 327 Ambulometer, 671 Amnesia, 355 Amphetamine, 149, 479, 595, 601, 665, 699, 719 Analgesia, 693 Anapyrexia, 399 Animal depression model, 605 Animal models, 21 Animal tests, 3 Anorectic drugs, 409 Antibiotics, 611 Anticholinergic, 753 Anticonvulsive mechanism, 759 Antidepressant, 219 Antidepressants, 725 Antiepileptic drugs, 639 Antimuscarinics, 425 Antinociception, 363, 495 Antiopiate peptides, 581 Antipredator defense, 509 Anxiety, 3, 13, 31, 57, 79, 85, 107, 123, 129, 169, 249, 255, 261, 509, 687 Anxiogenics, 21 Anxiolysis, 355, 65 1 Anxiolytics, 21, 51 Apomorphine, 469 Appetitive behavior, 333 Arthritis, 305 Arthropoda, 611 Arousal, 57 Associative, 575 Atropine sulfate, 753 Attention, 309 Atypical neuroleptic, 619 Baclofen, 565 Behavior, 343, 479 Behavioral despair test, 235 Behavioral models of anxiety, 677 Behavioural satiety sequence, 745 Behavioral sensitization, 671 Behavioral strategies, 113 Behavioral temperature regulation, Benzodiazepines, 31, 85, 149 l%Adrenoceptors, 211 l3-Receptors, 123 Beta-Carboline, 205 Binding protein, 305

399

Biogenic amines, 461 Biperiden, 425 Black-white box, 57 Black/white exploration Body temperature, 587 Body weight, 719 Bombesin, 705 Brain, 525 Brainstem, 377 Brightness discrimination, Buspirone, 51 Butorphanol, 461

INDEX

model,

13

425

Caffeine, 309, 469 Calcium channels, 657 Cardiovascular effects, 343 Catecholamines, 385 CCK, 255, 625 Central, 57 Cerebral dopamine metabolism, 787 Cerebral metabolism, 415 c-fos, 241 CGP 37849, 73 Chlordiazepoxide, 5 1, 175 Chloride uptake, 117 Choice, 547 Choice procedures, 547 Cholecystokinin, 625 Cholinergic system, 779 Chronic administration, 779 Chronic caffeine, 639 Chronic mild stress, 229 Circadian, 393 Circadian rhythm, 713 Circadian rhythms, 229 Cocaethylene, 491 Cocaine, 327, 343, 371, 439, 469, 491, 517, 533, 671 Cognition, 501 Cognitive performance, 309 Cold acclimation, 317 Cold stress, 555 Computer, 309 Conditioned fear stress, 687 Conditioned place preference, 671 Conditioned skin conductance responses, 129 Conditioning, 327 Conflict test, 107 Consummatory behavior, 333 Continuous analysis, 745 Core temperature, 3 17 Cortex, 385 Corticosterone, 51, 99, 205. 249. 587 Corticotropin releasing factor, 305 Cortisol, 219. 255, 299 Crab, 611 CRF, 299 Cyclic-ratio, 753 Cycloheximide, 611 Cytokines, 285 d-Amphetamine, 469, 517 Dansyl compounds, 581 DI, DZ dopamine receptors, DZ receptor density, 453 DA autoreceptors, 371 DAMGO, 317 XIII

235

Defeminization, 183 Defence, 175 Defensive burying, 113, 261 Delay of reward, 149 Delirium, 753 Delta2 opioid receptor, 363 Dependence, 46 1 Depression, 3, 129, 219, 299 Descending pathway, 363 Devazepide, 625 Diazepam, 93, 241, 249, 393, 651 Dihydropyridines, 657 Discriminative stimulus, 645 Distance-dependent-defense-hierarchy, 13 Diurnal rhythms, 65 1 DOPAC, 385 Dopamine, 385, 439, 453, 565, 619 Dopamine Dz receptors, 79 Dopaminel receptors, 687 Dopaminergic system, 779 Dopamine metabolites, 453 Dorsal hippocampus, 129 Dorsal raphe: 123 Dorsal raphe nucleus, 129 Dose, 547 Dose-response, 713 Drinking conflict test, 73 Drug abuse, 517 Drug addiction, 547 Drug discrimination, 517, 533, 645, 699 Drug discrimination learning, 439 Drug reinforcement, 547 Drug self-administration, 547, 719 DSLET, 363 Eating, 333 Eicosanoids, 285 8-OH-DPAT, 169 Electrochemical detection, 385 Electroshock, 639 Elevated plus-maze, 41, 79, 129, 355 Elevated plus-maze for anxiety, 195 Elevated T-maze, 129, 355 Endogenous opiates, 183 Endogenous opioid peptides, 581 Entrainment, 713 Ethanol, 399, 415, 525, 645 Ethanol intake, 657 Ethological analysis, 41, 159 Ethology, 79 Experimentally induced hyperphagia, 409 Exploration, 107 Exploratory behavior, 195, 651 Factor analysis, 31 Familiarity, 99 Fat, 719 Fear, 85, 117, 175, 261 Fear-potentiated startle, 261 Fear sensitization, 41 Feeding, 665, 705, 745 FSFamide, 581 FG 7142, 205 5,7-DHT, 677 5-HT, 85, 129, 385, 745 5-HT receptors (5-HTz, 5.HTIA), 5-HTIA, 149, 189

195

KEYWORD

XIV S-HTIA agonists, 677 S-HTIA autoreceptors, 143 S-HTIA receptors, 123, 509 5-HTr receptors, 533 5_Hydroxytryptamine, 211 5-Hydroxytryptamine (5-HT), 5-HydroxytryptaminezA, 211 Fixed interval, 5 1 Fixed-ratio schedules, 547 Flesinoxan, 249 Flight, 509 Fluoxetine, 143, 745 Food intake, 625, 719 Food restriction, 595 Foot shock, 205 Forced swimming test, 725 Forgetting, 453 Formalin test, 495 FR/DRL schedule, 425 Freezing, 93 Frontal cortex, 143

Intrahippocampal injection, Intruder sex, 175 Ipsapirone, 713 Isolation, 601 195

quail,

Kindling,

491

117

LAS rats, 525 L-Dooa plus benserazide, 779 L-NAME, 43 1 L-365.260, 625 Learning and memory, 41, 633 Ligand, 305 Limbic areas, 431 Locomotor activity, 219, 229, 355, 393, 469, 587, 787 Lordosis behavior, 403 Male rat sexual behavior, 605 Male sexual behavior, 601 Marking behavior, 219 Masculinization, 183 Maternal aggression, 175 mCPBG, 533 MDL 72222, 533 Median raphe nucleus, 129 Melatonin, 713 Memory, 611 Memory storage, 779 Metabolic rate, 555 Met-enkephalin, 277 Metergoline, 745 Methadone, 339, 547 Methamphetamine, 327, 671, 687 Metyrapone, 51 Mice, 13, 41, 175, 235, 491, 601, 677, 725 Mineralocorticoid receptor, 261 Mixed ~-HTIA/S-HT~+, antagonist, 509 MK-801, 565 Monitor, 479 Monoamine reuptake, 343 Monoamines, 211, 633 Mood, 501 Morphine, 371, 461, 485, 495, 575, 693 Morphine withdrawal, 787 Motor activity, 31, 235 Motor cortex, 759 Mouse, 249, 355 MPTP, 377 Multiple fixed ratio-variable interval schedule, 595

GABA, 85, 541 GABAA, 363 GABAA receptor, 117, 205 GABAa, 363 y-Aminobutyric acid, 393 Gastrin-releasing peptide, 705 Gastrointestinal, 625 GBR 12909, 517 General anesthetic, 501 Generalization, 699 Generalized seizures, 759 Ginseng extract, 671 Glucocorticoid receptor, 261 Glucocorticoids, 3, 285 Glucose, 249 Glyburide, 725 Glyceryl trinitrate, 73 1 Grooming, 219 Group housing, 601 Habituation, 93, 611 Handling, 21 HAS rats, 525 Head twitch, 509 Heart rate, 587 Heat escape, 317 HIAA, 385 Hippocampus, 415 Hole board, 31, 107, 355 HPA axis. 219. 277. 285 HPLC, 385 Humans, 65, 501 HVA, 385 Hyperactivity, 123 Hyperthermia, 249 Hypothalamic-pituitary-adrenal Hypothermia, 399, 555

Japanese

73

axis, 57

Immature rat, 555 Immune function, 3, 299 Immune response, 277 Immunohistochemistry, 241 Indirect dopamine agonists, 235 Individual differences, 21 I, 665, 699 Induced feeding, 771 Inflammation, 305 Infrared, 479 Insulin, 409 Interictal activity, 759 Intracerebral microdialysis, 143

Naloxone, 277, 771 Naloxonemethiodide, 333 Neonatal, 189 Neonatal antidepressant drugs, Neonatal clorimipramine, 605 Neural pathways, 409 Neuroactive steroids, 205 Neuroimmunology, 285 Neuroleptics, 541 Neuromedin B, 705 Neuromedin C, 705 Neuropeptide FF, 581 Neuropeptide Y, 77 1 Neurotensin, 525 Neurotransmitters, 299 NGF, 65 Nicotine, 241, 581, 587 Nicotine abstinence, 581

605

INDEX

Nicotine dependence, 581 Nicotine withdrawal, 581 Nicotinic receptors, 587 Nimodipine stereoselectivity, 657 Nitric oxide, 431, 731 Nitric oxide synthase inhibitors, 731 Nitrous oxide, 501 Nonassociative, 575 Noradrenaline, 211 Noradrenergic system, 779 Norepinephrine, 219 Novel pharmacodynamic action, 343 Novelty, 99 Nucleus accumbens, 565, 665 Nutrient selection, 719 Offence, 175 Ondansetron, 533 1-Aminocyclopropanecarboxylic acid, 73 Ontogeny, 93 Ontogeny of the control of food intake, 333 Open field, 739 Operant behavior, 425 Operant behaviour, 149 Operant food intake, 255 Opiates, 693 Opioid antagonists, 333, 645 Opioids, 547 Oral naltrexone, 183 Oral route, 547 Orosensory control, 333 Owl calls, 13 Oxidative stress, 377 Pain, 693 Palatability, 693, 739 Panic, 255, 509 Parkinson’s disease, 619 p-CPA, 677 Penicillin, 759 Penile erections, 787 Peripheral, 57 Peripheral administration, 73 Periadolescence, 99 Perseveration, 753 Phenobarbital, 633 Phentermine, 5 17 Phobia, 31 Physiologic regulation, 65 Pigeons, 485 Pittsburg Yoshida rat, 43 1 Pituitary, 51 Place preference, 37 I, 657 Place preference paradigm, 339 Plasma PB levels, 633 Play, 99 Plus-maze, 13, 31, 123 Posterior thalamus, 759 Postreinforcement pause (PRP), 753 Potassium channel blocker, 725 Poultry, 85 Pre- and postsynaptic receptors, 677 Preclamol, 371 Predation, 13 Predator assessment, 509 Pregnancy, 305 Pregnenolone, 205 Prenatal development, 183 Prior screening, 175 Progesterone, 205 Progressive-ratio schedule, 485 “Psychogenic” amnesia, 453

KEYWORD

INDEX

Psychomotor, 501 p-Tyramine, 453 Purposeless chewing, Quinpirole,

xv

619

371, 787

Rat(s), 13, 73, 93, 143, 149, 169, 229, 317, 339, 355, 371, 377, 415, 657, 665, 699, 713, 753, 759 Rate constancy, 595 Rate dependency, 595 Receptor agonists, 149 Receptors, 211, 625 Regional neurochemical brain patterns, 453 Reinforcement magnitude, 547 Reinforcing effect, 671 Relative reinforcement, 547 REM sleep deprivation, 385 Restraint stress, 129 Retest, 41 Retrieval training, 453 Reverse tolerance, 671 Reward, 371 Rewarding stimulus, 657 Rhesus monkeys, 517, 547 Risk assessment, 79, 219 Rodents, 65 Rotational behavior. 469 S-20098, 7 13 S 21357, 509 Salbutamol, 409 Satiety, 625, 745 Schedule-controlled behavior, Schizophrenia, 687 Scopolamine, 41, 57 Sedation, 355 Seizures, 491, 731 Selective breeding, 495

753

Sensitivity, 699 Sensitization, 327 Serotonin, 143, 189, 509, 619 Serotoninergic system, 779 Serotonin reuptake inhibitors, 149 Set point, 399 7-OH-DPAT, 79 Sex differences, 189 Sex steroids, 269 Sexual behavior, 159, 195, 403 Sexual differentiation, 183 Sexual dimorphism, 269 Sexual maturation, 269 Sexual preference, 195 Simulated public speaking, 129 6-Hydroxydopamine (6-OHDA), 469 6-Monoacetyimorphine, 363 SKF-38393. 469 Social competition, 169 Social interactions, 99, 107 Sodium channel, 343 Sodium mercaptoacetate, 409 Soman, 731 Spatial scaling, 479 Staircase maze, 779 Startle, 93 Stereotypy, 787 Strain differences, 21, 107 Stress, 3, 21, 51, 57, 65, 113, 129, 211, 241, 249, 255, 277, 285, 299 Stress resistance, 211 Striatum, 377, 385 Stroop task, 309 Subjective, 501 Sucrose, 693, 7 19 Sue-Try-N-(Me)-Nle-Asp-Phe-NH*, 255 Sugar, 665 Sweet taste, 693 Tail flick, 575, 693 Tardive dyskinesia, 541

Taste aversion, 657 Telethermistors, 317 Temperature regulation, 399 Temporal scaling, 479 Testosterone, 195 Thermoregulation, 555 Theta, 57 3,Alpha-21-dihydroxy-5alpha-pregnan-20-one 205 [‘HlFlunitrazepam binding, 43 1 Thymic cellularity, 269 Thymocyte phenotypic characteristics, Time-dependent effects, 651 Tolerance, 485, 575 Training with retention, 453 Training without retention, 453 Tremor, 619 Trihexyphenidyl, 425 2-Deoxy-o-glucose, 409 Unsignaled morphine delivery, U-Shaped doseresponse curve,

575 425

Vacuous chewing movements, 541, 619 Ventral hippocampus, 123 Ventral tegmental area, 565 Voluntary alcohol drinking, 739 Voluntary consumption, 415 Waiting capacity, 149 WAY-100135, 159 WAY-100635, 143 Wild animals, 13 Wild house mice, 113 Yawning, Zacopride,

787 533

269